Role of Salbutamol and Furosemide in TTN

Armed Forces Hospital, Pakistan

Status and phase: Completed; Phase 3

Conditions: Transient Tachypnea of the Newborn

Treatments: Drug: Furosemide Injection

Study type: Interventional

Funder types: Other

Identifiers

NCT03208894

TTN

Details and patient eligibility

About

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Enrollment: 100 patients

Sex: All

Ages: 1 hour to 7 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• all newborn babies with clinically diagnosed TTN

Exclusion criteria

• babies less than 34 weeks babies with congenital malformations and CHD

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 4 patient groups

with salbutamol

Experimental group

Treatment:

Drug: Furosemide Injection

with furosemide

Experimental group

Treatment:

Drug: Furosemide Injection

both furosemide and salbutamol

Experimental group

Treatment:

Drug: Furosemide Injection

no inervention

No Intervention group